Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
about
The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.Anti-inflammatory effects of the new generation synthetic surfactant CHF5633 on Ureaplasma-induced cytokine responses in human monocytes.Expression of surfactant protein B is dependent on cell density in H441 lung epithelial cells.
P2860
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
@ast
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
@en
type
label
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
@ast
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
@en
prefLabel
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
@ast
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
@en
P2093
P2860
P1433
P1476
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.
@en
P2093
Barbara Ottensmeier
Christian P Speer
Kirsten Glaser
Markus Fehrholz
Silvia Seidenspinner
Steffen Kunzmann
Tore Curstedt
P2860
P304
P356
10.1371/JOURNAL.PONE.0153578
P407
P577
2016-04-14T00:00:00Z